Dopamine accelerates recovery from cyclophosphamide-induced leukopenia

Experimental Oncology

Volumn 22, Issue 3, 2000, Pages 153-156

  Ray, M R ^a   Lakshmi, C ^a   Deb, C ^a   Pal, B ^a  

^a CHITTARANJAN NATIONAL CANCER INSTITUTE   (India)

Author keywords

Cyclophosphamide; Dopamine; Mice; Myelosuppression; Recovery

Indexed keywords

CYCLOPHOSPHAMIDE; DOPAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; BONE MARROW; BONE MARROW SUPPRESSION; CANCER THERAPY; CONTROLLED STUDY; CYTOCHEMISTRY; DISEASE SEVERITY; DOPAMINE BRAIN LEVEL; DOSE RESPONSE; DRUG EFFECT; ERYTHROCYTE COUNT; FEMALE; LEUKOCYTE DIFFERENTIAL COUNT; LEUKOPENIA; MALE; MOUSE; NEUTROPENIA; NONHUMAN; SPLEEN CELL; THROMBOCYTE COUNT;

EID: 0033729351     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Landsberg L, Voung JB. Physiology and pharmacology of the autonomic nervous system. In: AS Fauci, E Braunwald, KJ Isselbacher, JD Wilson, JB Martin, DL Kasper, SL Hauser, DL Longo, eds. Harrison's Principles of Internal Medicine. Vol. 1, 14th ed. McGraw-Hill 1998: 430-42.
2. Hinds CJ, Watson D. Intensive Care: A Concise Textbook. W.B. Saunders Co, 4th ed. 1997: 90-3.
3. Dasgupta PS, Lahiri T. Antitumor effect of i.p. dopamine in mice bearing Ehrlich ascites carcinoma. J Cancer Res Clin Oncol 1987; 113: 363-8.
4. Ray MR, Dasgupta PS, Basu S, Lahiri T. Dopamine inhibits tumor growth and concomitantly stimulates erythrocyte and platelet production in experimental tumor bearing mice. Biogenic Amines 1988; 5: 475-81.
5. Ray MR, Nandi SK, Lahiri T. Effect of dopamine on pluripotent hematopoietic stem cells (CFU-S) of mice. Biogenic Amines 1994; 10: 555-9.
6. Hoagland H C. Hematological complications of cancer chemotherapy. Semin Oncol 1982; 9: 95-102.
7. Pizzo PA. Granulocytopenia and cancer therapy. Past problems, current solutions and future challenges. Cancer 1984; 54: 2649-66.
8. Yeager A M, Levin FC, Levin J. Effects of cyclophosphamide on murine bone marrow and splenic megakaryocyte-CFC, granulocyte-macrophage-CFC, and peripheral blood cell levels. J Cell Physiol 1982; 112: 222-228.
9. Bain BJ. Basic Hematological Techniques. In: JV Dacie, SM Lewis, eds. Practical Hematology. 8th ed. Churchill - Livingstone, 1996: 49-82.
10. Ray MR, Raychowdhury J. Studies on the bone marrow and splenic erythropoiesis in mice bearing Ehrlich ascites carcinoma. Curr Sci 1981; 50: 1020-3.
11. Catovsky D. Leukocyte cytochemical and immunochemical techniques. In: JV Dacie, SM Lewis, eds. Practical Hematology. 8th ed Churchill-Livingstone, 1996: 143-74.
12. Smith A, Bruton J. Staining and impregnation technique working introductions. In: GB Carruthers, ed. A Color Atlas of Histological Staining Techniques. Wolfe Medical Publications, 1977: 165-6.
13. 59Fe labeling. Proc Soc Exp Biol Med 1963; 112: 1058-62.
14. Karnovsky MJ, Roots L. A direct coloring thiocholine method for cholinesterase. J Histochem Cytochem 1964; 12: 219-21.
15. Devereux S, Linch D. Hematopoietic growth factors. Qr J Med 1990; 75: 537-50.
16. Lind M J, Gumbrell L, Cantwell BMJ, Millward MJ, Simmonds D, Proctor M, Chapman F, McCann E, Middleton I, Calvert AH. The use of granulocyte colony stimulating factor to deliver four cycles of ifosfamide and epirubicin every 14 days in women with advanced or metastatic breast cancer. Brit J Cancer 1995; 71: 610-3.
17. Bukowski R M, Murthy S, McLain D, Finke J, Anderson S, Tubs R, Bauer L, Givson V, Budd GT, Thomassen MJ. Phase I trial of recombinant granulocyte macrophase colony stimulating factor in patients with lung cancer. Clinical and immunological effects. J Immunother 1993; 13: 267-75.
18. Sagawa K, Ueno Y, Kataoka T. In vivo tumor growth enhancement by granulocyte colony stimulating factor. Jpn J Cancer Res 1991; 82: 440-7.
19. Berdel WE, Danhauser-Riedl S, Steinhauser G Winton E. Various human hematopoietic growth factors (Interleukin 3, GM-CSF, G-CSF) stimulate clonal growth of non-hematopoietic tumor cells. Blood 1989; 73: 80-3.
20. Noda I, Fujieda S, Ohtsubo T, Tsuzuki H, Tanaka N, Sunaga H, Saito H Granulocyte-colony-stimulating factor enhances invasive potential of human head-and-neck-carcinoma cell lines. Int J Cancer 1999; 80: 78-84.
21. Spangrude GJ, Johnson GR. Resting and activated subsets of mouse multipotent hematopoietic stem cells. Proc Natl Acad Sci USA 1990; 87: 7433-7.
22. Brodsky I, Dannis LH, Kahn SB, Brady LW. Normal mouse crythropoiesis. 1. The role of the spleen in mouse erythropoiesis. Cancer Res 1966; 26: 198-201.
23. Lelieveld P, Vijgh WF, Velzen DV. Preclinical toxicology of platinum analogs in dogs. Eur J Cancer Clin Oncol 1987; 23: 1147-54.